FORESEE: a tool for the systematic comparison of translational drug response modeling pipelines
Open Access
- 1 March 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (19) , 3846-3848
Abstract
Translational models that utilize omics data generated in in vitro studies to predict the drug efficacy of anti-cancer compounds in patients are highly distinct, which complicates the benchmarking process for new computational approaches. In reaction to this, we introduce the uniFied translatiOnal dRug rESponsE prEdiction platform FORESEE, an open-source R-package. FORESEE not only provides a uniform data format for public cell line and patient datasets, but also establishes a standardized environment for drug response prediction pipelines, incorporating various state-of-the-art pre-processing methods, model training algorithms and validation techniques. The modular implementation of individual elements of the pipeline facilitates a straightforward development of combinatorial models, which can be used to re-evaluate and improve already existing pipelines as well as to develop new ones. FORESEE is licensed under GNU General Public License v3.0 and available at https://github.com/JRC-COMBINE/FORESEE and https://doi.org/10.17605/OSF.IO/RF6QK, and provides vignettes for documentation and application both online and in the Supplementary Files 2 and 3. Supplementary data are available at Bioinformatics online.Keywords
All Related Versions
Funding Information
- Bayer AG
This publication has 21 references indexed in Scilit:
- Open source machine-learning algorithms for the prediction of optimal cancer drug therapiesPLOS ONE, 2017
- Correlating chemical sensitivity and basal gene expression reveals mechanism of actionNature Chemical Biology, 2015
- PharmacoGx: an R package for analysis of large pharmacogenomic datasetsBioinformatics, 2015
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseNature Medicine, 2015
- SYSTEMATIC ASSESSMENT OF ANALYTICAL METHODS FOR DRUG SENSITIVITY PREDICTION FROM CANCER CELL LINE DATA2013
- An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small MoleculesCell, 2013
- An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor ResistanceClinical Cancer Research, 2013
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast CancerJournal of Clinical Oncology, 2010
- Patterns of Resistance and Incomplete Response to Docetaxel by Gene Expression Profiling in Breast Cancer PatientsJournal of Clinical Oncology, 2005